LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

McKesson Corp

Отворен

СекторЗдравеопазване

826.86 0.45

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

826.86

Максимум

829.42

Ключови измерители

By Trading Economics

Приходи

426M

1.2B

Продажби

5.3B

103B

P/E

Средно за сектора

25.575

78.892

EPS

9.86

Дивидентна доходност

0.36

Марж на печалбата

1.173

Служители

43,000

EBITDA

212M

1.5B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+14.1% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.36%

2.38%

Следващи печалби

4.02.2026 г.

Следваща дата на дивидент

2.01.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-235M

102B

Предишно отваряне

826.41

Предишно затваряне

826.86

Настроения в новините

By Acuity

33%

67%

92 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.12.2025 г., 21:41 ч. UTC

Придобивния, сливания и поглъщания

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24.12.2025 г., 14:57 ч. UTC

Придобивния, сливания и поглъщания

Accenture to Acquire Cabel Industry from Fibonacci Group

24.12.2025 г., 12:48 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead

24.12.2025 г., 12:21 ч. UTC

Значими двигатели на пазара

Nike Shares Tick Up After Apple CEO Tim Cook Buys $2.9 Million of Its Stock

24.12.2025 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24.12.2025 г., 21:26 ч. UTC

Придобивния, сливания и поглъщания

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24.12.2025 г., 19:35 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

24.12.2025 г., 19:35 ч. UTC

Пазарно говорене

Treasury Yields Decline Ahead of Christmas -- Market Talk

24.12.2025 г., 19:09 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

24.12.2025 г., 19:09 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24.12.2025 г., 19:06 ч. UTC

Пазарно говорене

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24.12.2025 г., 19:03 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24.12.2025 г., 17:20 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

24.12.2025 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

24.12.2025 г., 17:08 ч. UTC

Придобивния, сливания и поглъщания

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24.12.2025 г., 16:53 ч. UTC

Придобивния, сливания и поглъщания

Nike Climb Boosts Dow, S&P 500 -- WSJ

24.12.2025 г., 16:31 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24.12.2025 г., 16:28 ч. UTC

Придобивния, сливания и поглъщания

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24.12.2025 г., 16:17 ч. UTC

Пазарно говорене

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24.12.2025 г., 15:33 ч. UTC

Придобивния, сливания и поглъщания

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24.12.2025 г., 15:30 ч. UTC

Придобивния, сливания и поглъщания

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24.12.2025 г., 15:19 ч. UTC

Придобивния, сливания и поглъщания

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24.12.2025 г., 14:49 ч. UTC

Придобивния, сливания и поглъщания

Mexico's Ollamani Sells Stake in Azteca Stadium

24.12.2025 г., 14:19 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24.12.2025 г., 14:08 ч. UTC

Придобивния, сливания и поглъщания

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24.12.2025 г., 14:06 ч. UTC

Пазарно говорене

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24.12.2025 г., 13:24 ч. UTC

Пазарно говорене

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24.12.2025 г., 12:59 ч. UTC

Придобивния, сливания и поглъщания

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24.12.2025 г., 12:51 ч. UTC

Придобивния, сливания и поглъщания

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

24.12.2025 г., 12:38 ч. UTC

Придобивния, сливания и поглъщания

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

14.1% нагоре

12-месечна прогноза

Среден 942.18 USD  14.1%

Висок 1,000 USD

Нисък 880 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

14 ratings

12

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

92 / 374 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat